Profile for TRACON Pharmaceuticals Inc. (TCON)

$ 1.88   0.03 (+1.62%) Volume: 97.12k 4:00 PM EDT 7-Jul-2020
After Hours:  $ 1.90   0.02 (+1.06%) Volume: 408 6:58 PM EDT 7-Jul-2020
Business Description:
TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
Address: 4350 La Jolla Village Drive, Suite 800, San Diego, CA, USA, 92122
Telephone: +1 858 550-0780 Website:
Facsimile: +1 858 550-0786 Email: [email protected]
CEO: Charles P. Theuer
Employees: 19 Market Cap: 10.34m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1394319
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Medicinal and Botanical Manufacturing (325411)
SIC: Biological Products, Except Diagnostic Substances (2836)